LUXEMBOURG INSTITUTE OF HEALTH

Luxembourg Institute of Health’s mission is to impact on patients by performing and translating excellent biomedical research.

The Luxembourg Institute of Health (LIH) is a public research organisation at the forefront of biomedical sciences. LIH aims to perform research that transcends the boundaries of individual diseases and that can be tangibly applied in the clinical practice to address unmet needs, thus positively affecting health outcomes for patients. This translational and transversal research strategy, combined to the increasing appreciation of the role of the immune system in determining disease, has led LIH to focus on four priority areas:

CANCER,

IMMUNOLOGICAL DISORDERS,

NEURODEGENERATIVE DISEASES,

PREVENTIVE MEDICINE.

With its strong expertise in population health, oncology, infection and immunity as well as storage and handling of biological samples, LIH investigates disease mechanisms to develop new diagnostics, innovative therapies and effective tools for personalised medicine.

With its strong expertise in population health, oncology, infection and immunity as well as storage and handling of biological samples, LIH investigates disease mechanisms to develop new diagnostics, innovative therapies and effective tools for personalised medicine.